Affiliation:
1. Fiona Stanley Hospital Perth Western Australia Australia
2. Edith Cowan University Perth Western Australia Australia
3. UPMC Hillman Cancer Center and University of Pittsburgh Pittsburgh Pennsylvania USA
Abstract
The field of melanoma therapeutics is moving quickly with the first approval of adoptive cell transfer in solid tumors. Moreover, individualized neoantigen therapies, PRAME‐targeting strategies, oncolytic viruses, and more are rapidly emerging.